🇺🇸 FDA

Company profile · Sponsor

Candel

Candel Therapeutics

CADL · NYSE biotech NEEDHAM, MA, USA
Pipeline
12
Drugs
0
Patents
0

Quick answer

Candel (CADL) is a biotech company. headquartered in NEEDHAM, MA, USA. listed on NYSE. NovaPharmaNews links 12 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker CADL
Exchange NYSE
Company type biotech
Headquarters NEEDHAM, MA, USA
SEC CIK 0001841387

Pipeline (12)

Search pipeline →

  1. Aglatimagene besadenovec + valacyclovir

    Candel

    Prostate Cancer

    phase 3 mab active

    1 trial

  2. Aglatimagene besadenovec

    Candel

    Borderline Resectable Pancreatic Adenocarcinoma

    phase 2 mab active

    1 trial

  3. Aglatimagene besadenovec

    Candel

    Non Small Cell Lung Cancer

    phase 2 mab active

    1 trial

  4. CAN-2409

    Candel

    Malignant Glioma

    phase 2 mab completed

    1 trial

  5. aglatimagene besadenovec

    Candel

    Prostate Cancer

    phase 2 mab active

    1 trial

  6. aglatimagene besadenovec + valacyclovir

    Candel

    Prostate Cancer Patients Treated by Radiotherapy

    phase 2 mab active

    1 trial

  7. AdV-tk

    Candel

    Glioma, Malignant

    phase 1 mab completed

    1 trial

  8. AdV-tk

    Candel

    Malignant Glioma

    phase 1 mab completed

    2 trials

  9. AdV-tk

    Candel

    Pancreatic Adenocarcinoma

    phase 1 mab completed

    1 trial

  10. AdV-tk + valacyclovir

    Candel

    Malignant Pleural Effusion

    phase 1 mab completed

    1 trial

  11. CAN-2409 + valacyclovir

    Candel

    Lung Cancer

    phase 1 mab completed

    1 trial

  12. rQNestin

    Candel

    Malignant Glioma of Brain

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is Candel?

Candel (CADL) is a biotech company. headquartered in NEEDHAM, MA, USA. listed on NYSE. NovaPharmaNews links 12 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Candel sponsor?

We track 12 ClinicalTrials.gov-linked programs for Candel, including Aglatimagene besadenovec + valacyclovir and 11 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Candel company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.